Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 167

1.

Improving the Treatment and Management of Endometriosis: An Overview of Current and Novel Approaches.

Ofer A, Shulman LP, Singh SS.

Am J Obstet Gynecol. 2016 May;214(5):672. doi: 10.1016/j.ajog.2015.12.022. Epub 2015 Dec 19. No abstract available.

PMID:
26710996
2.

Does a History-Indicated Cerclage Affect Gestational Age at Delivery in Women with Evidence of Recurrent Cervical Insufficiency?

Ginsberg NA, Miller E, Gerber S, Dungan JS, Shulman LP.

J Reprod Med. 2015 Sep-Oct;60(9-10):389-91.

PMID:
26592063
3.

Commentary on "Limited Uptake of Planned Intrauterine Devices During the Postpartum Period".

Shulman LP.

South Med J. 2015 Aug;108(8):469-70. doi: 10.14423/SMJ.0000000000000320. No abstract available.

PMID:
26280770
4.

Walking the Fine Line between Science and Culture.

Shulman LP.

Drug Saf. 2015 Sep;38(9):769-71. doi: 10.1007/s40264-015-0324-6. No abstract available.

PMID:
26173434
5.

Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods.

Bahamondes L, Valeria Bahamondes M, Shulman LP.

Hum Reprod Update. 2015 Sep-Oct;21(5):640-51. doi: 10.1093/humupd/dmv023. Epub 2015 Jun 1. Review.

PMID:
26037216
6.

Commentary on "care of the adult patient with down syndrome".

Shulman LP.

South Med J. 2014 Nov;107(11):722-3. doi: 10.14423/SMJ.0000000000000194. No abstract available.

PMID:
25365442
7.

Postpartum glucose tolerance in women with gestational diabetes using levonorgestrel intrauterine contraception.

Kiley JW, Hammond C, Niznik C, Rademaker A, Liu D, Shulman LP.

Contraception. 2015 Jan;91(1):67-70. doi: 10.1016/j.contraception.2014.08.004. Epub 2014 Aug 12.

PMID:
25193535
8.

Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hops.

van Breemen RB, Yuan Y, Banuvar S, Shulman LP, Qiu X, Alvarenga RF, Chen SN, Dietz BM, Bolton JL, Pauli GF, Krause E, Viana M, Nikolic D.

Mol Nutr Food Res. 2014 Oct;58(10):1962-9. doi: 10.1002/mnfr.201400245. Epub 2014 Sep 16.

9.

The best prophet of the future is the past: oral contraception and novel components.

Shulman LP.

J Womens Health (Larchmt). 2014 Mar;23(3):195-6. doi: 10.1089/jwh.2014.4733. Epub 2014 Feb 14. No abstract available.

PMID:
24528194
10.

Has the pendulum begun to swing back?

Shulman LP.

Menopause. 2014 Mar;21(3):211-2. doi: 10.1097/GME.0000000000000212. No abstract available.

PMID:
24496090
11.

Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women.

Walega DR, Rubin LH, Banuvar S, Shulman LP, Maki PM.

Menopause. 2014 Aug;21(8):807-14. doi: 10.1097/GME.0000000000000194.

12.

Changing convention in combination oral contraceptives: estradiol and nomegestrol acetate in a monophasic 24/4 regimen.

Shulman LP.

J Fam Plann Reprod Health Care. 2013 Jul;39(3):211-6. doi: 10.1136/jfprhc-2013-100605. Epub 2013 May 24. Review.

PMID:
23709606
13.

Objective cognitive performance is related to subjective memory complaints in midlife women with moderate to severe vasomotor symptoms.

Drogos LL, Rubin LH, Geller SE, Banuvar S, Shulman LP, Maki PM.

Menopause. 2013 Dec;20(12):1236-42. doi: 10.1097/GME.0b013e318291f5a6.

14.

Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.

Bitzer J, Amy JJ, Beerthuizen R, Birkhäuser M, Bombas T, Creinin M, Darney PD, Vicente LF, Gemzell-Danielsson K, Imthurn B, Jensen JT, Kaunitz AM, Kubba A, Lech MM, Mansour D, Merki G, Rabe T, Sedlecki K, Serfaty D, Seydoux J, Shulman LP, Sitruk-Ware R, Skouby SO, Szarewski A, Trussell J, Westhoff C.

J Fam Plann Reprod Health Care. 2013 Jul;39(3):156-9. doi: 10.1136/jfprhc-2013-100624. Epub 2013 Apr 12. No abstract available.

PMID:
23585363
15.

Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.

Bitzer J, Amy JJ, Beerthuizen R, Birkhäuser M, Bombas T, Creinin M, Darney PD, Vicente LF, Gemzell-Danielsson K, Imthurn B, Jensen JT, Kaunitz AM, Kubba A, Lech MM, Mansour D, Merki G, Rabe T, Sedlecki K, Serfaty D, Seydoux J, Shulman LP, Sitruk-Ware R, Skouby SO, Szarewski A, Trussell J, Westhoff C.

Eur J Contracept Reprod Health Care. 2013 Jun;18(3):143-7. doi: 10.3109/13625187.2013.792637. Epub 2013 Apr 12. No abstract available.

PMID:
23578274
16.

The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer.

Pilarski R, Patel DA, Weitzel J, McVeigh T, Dorairaj JJ, Heneghan HM, Miller N, Weidhaas JB, Kerin MJ, McKenna M, Wu X, Hildebrandt M, Zelterman D, Sand S, Shulman LP.

PLoS One. 2012;7(5):e37891. doi: 10.1371/journal.pone.0037891. Epub 2012 May 25.

17.

In the nick of time: Despite 2 treatments a cervical ectopic pregnancy continued to advance.

Miller ES, Marko K, Cohen L, Dungan JS, Shulman LP.

Am J Obstet Gynecol. 2012 May;206(5):450.e1-2. doi: 10.1016/j.ajog.2012.01.027. Epub 2012 Jan 28. No abstract available.

PMID:
22342896
18.
19.

The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.

Shulman LP.

Am J Obstet Gynecol. 2011 Oct;205(4 Suppl):S9-13. doi: 10.1016/j.ajog.2011.06.057. Review.

PMID:
21961825
20.

Estradiol valerate and dienogest: a new approach to oral contraception.

Kiley JW, Shulman LP.

Int J Womens Health. 2011;3:281-6. doi: 10.2147/IJWH.S22645. Epub 2011 Aug 18.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk